Alkermes ALKS
NASDAQ ALKS
$45.25 -0.24 (-0.53%)
As of: Sep 9, 2026 · 2:47 PM EDT

Alkermes (ALKS) EV to CFO (2010 - 2026)

Alkermes' (ALKS) quarterly EV to CFO came in at 55.95 in Q2 2026, up 126.72% year-over-year from 24.68 in Q2 2025, and up 272.54% quarter-over-quarter from 32.43 in Q1 2026.

Analysis

Alkermes (ALKS) EV to CFO (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported EV to CFO for 17 consecutive years, with 55.95 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to CFO rose 126.72% year-over-year to 55.95 in Q2 2026; TTM through Jun 2026 was 32.34, a 354.55% increase from a year earlier, with the FY2025 full-year figure at 6.75, down 24.27% from the prior year.
  • EV to CFO was 55.95 for Q2 2026 at Alkermes, up from 32.43 in the prior quarter.
  • Over five years, EV to CFO peaked at 4941.93 in Q3 2022 and troughed at 1869.7 in Q2 2022.
  • A 5-year average of 393.92 and a median of 36.88 in 2023 frame the typical range for EV to CFO.
  • The widest YoY moves for EV to CFO: up 9142.41% in 2022, down 1909.32% in 2022.
  • Over 5 years, EV to CFO stood at 3521.21 in 2022, then sank by 98.98% to 35.98 in 2023, then plunged by 42.89% to 20.55 in 2024, then gained by 0.55% to 20.66 in 2025, then jumped by 170.78% to 55.95 in 2026.
  • The last three EV to CFO figures came in at 55.95 (Q2 2026), 32.43 (Q1 2026), and 20.66 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.03 Bn 625.27 Bn 17.26 Bn
2 AbbVie 441.99 Bn 435.42 Bn 12.70 Bn
3 Merck 366.30 Bn 359.16 Bn 12.21 Bn
4 Novartis Ag 266.55 Bn 258.86 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn
7 Revolution Medicines 44.13 Bn 44.13 Bn -
8 Incyte 25.53 Bn 20.99 Bn 1.57 Bn
9 United Therapeutics 21.51 Bn 18.85 Bn 683.80 Mn
10 Alkermes 7.56 Bn 6.91 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.95
Mar 31, 2026 -32.43
Dec 31, 2025 20.66
Sep 30, 2025 37.79
Jun 30, 2025 24.68
Mar 31, 2025 46.14
Dec 31, 2024 20.55
Sep 30, 2024 44.36
Jun 30, 2024 21.38
Mar 31, 2024 181.67
Dec 31, 2023 35.98
Sep 30, 2023 37.92
Jun 30, 2023 20.32
Mar 31, 2023 -191.57
Dec 31, 2022 3,521.21
Sep 30, 2022 4,941.93
Jun 30, 2022 -1,869.70
Mar 31, 2022 173.69
Dec 31, 2021 104.13
Sep 30, 2021 53.47